home / stock / gnpx / gnpx news


GNPX News and Press, Genprex Inc. From 02/19/20

Stock Information

Company Name: Genprex Inc.
Stock Symbol: GNPX
Market: NASDAQ
Website: genprex.com

Menu

GNPX GNPX Quote GNPX Short GNPX News GNPX Articles GNPX Message Board
Get GNPX Alerts

News, Short Squeeze, Breakout and More Instantly...

GNPX - GRPN, SLS, ENPH and SSTI among midday movers

Gainers: Myomo (NYSEMKT: MYO ) +48% . More news on: Myomo, Inc., Enphase Energy, Inc., Altisource Asset Management Corporation, Stocks on the move, , Read more ...

GNPX - Genprex down 17% on equity offering

Gene therapy developer Genprex ( GNPX -16.8% ) slumps on increased volume in early trade in reaction to its direct offering of 5M common shares to institutional investors at $3.50 per share yielding gross proceeds of ~$17.5M. More news on: Genprex, Inc., Healthcare stocks news, Stocks ...

GNPX - Genprex, Inc. Prices $17,500,000 Common Stock Offering Priced At-The-Market and Without Warrants

Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX ), a clinical stage gene therapy company developing a new and potentially life-saving approach to treating some of the world’s most deadly cancers based upon a novel proprietary technology platform,...

GNPX - XXII, GLOP, IMGN and CC among midday movers

Gainers : BioXcel Therapeutics (NASDAQ: BTAI )  +58% . More news on: BioXcel Therapeutics, Inc., Genprex, Inc., ImmunoGen, Inc., Stocks on the move, , Read more ...

GNPX - NVDA, ACB among premarket gainers

BioXcel Therapeutics (NASDAQ: BTAI ) +67% . More news on: BioXcel Therapeutics, Inc., Canopy Growth Corporation, Blink Charging Co., Stocks on the move, , Read more ...

GNPX - INO, RDFN, SPWR and NUS among midday movers

Gainers:  CounterPath (NASDAQ: CPAH ) +32% . More news on: CounterPath Corporation, Genprex, Inc., Happiness Biotech Group Limited, Stocks on the move, , Read more ...

GNPX - s, REXN, DBD and PYX among midday movers

Gainers : Rexahn Pharmaceuticals (NASDAQ: REXN )  +85% . More news on: Rexahn Pharmaceuticals, Inc., Sprint Corporation, Genprex, Inc., Stocks on the move, , Read more ...

GNPX - Genprex up 29% on license for diabetes gene therapy

Nano cap Genprex ( GNPX +28.6% ) is up on more than double normal volume in reaction to its agreement with the University of Pittsburgh for exclusive rights to a gene therapy for the potential cure of type 1 and type 2 diabetes. More news on: Genprex, Inc., Healthcare stocks news, Stoc...

GNPX - S, TMUS among premarket gainers

Sprint (NYSE: S ) +74%  after judge approves T-Mobile merger . More news on: Sprint Corporation, Rexahn Pharmaceuticals, Inc., ZK International Group Co., Ltd., Stocks on the move, Read more ...

GNPX - Biotech Brief: Global Diabetes Drug Market Could Reach $78 Billion By End Of 2026

February 11, 2020 Palm Beach, FL –February 11, 2020 – The global diabetes drugs market size was valued at USD $48,753.1 Million in 2018, is projected to reach USD 78,261.7 Million by the end of 2026, exhibiting a CAGR of 6.1%, according to industry reports. Rise in obesi...

Previous 10 Next 10